Radiation boosts immunotherapy in lung cancer? new trial aims to find out
NCT ID NCT07353476
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with stage III non-small cell lung cancer who had chemotherapy plus immunotherapy before surgery, and still had cancer in their lymph nodes after the tumor was removed. Half will get standard immunotherapy alone after surgery, and the other half will get immunotherapy plus radiation to the lymph nodes. The goal is to see if the combination helps keep the cancer from coming back longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy and an anti-PD-1 immunotherapy drug
What this could lead to
If it works, this could point toward a more effective treatment plan for lung cancer patients who still have cancer in their lymph nodes after surgery and chemotherapy.
What could go wrong
This is a small, early-phase study with only 38 participants, so results may not apply to everyone. Adding radiation also raises risks of side effects like lung inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.